1. Disease-Causing SDHAF1 Mutations Impair Transfer of Fe-S Clusters to SDHB.
- Author
-
Maio N, Ghezzi D, Verrigni D, Rizza T, Bertini E, Martinelli D, Zeviani M, Singh A, Carrozzo R, and Rouault TA
- Subjects
- Amino Acid Motifs, Amino Acid Sequence, Electron Transport Complex II metabolism, Female, HEK293 Cells, Humans, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, Infant, Infant, Newborn, Leukoencephalopathies pathology, Molecular Chaperones metabolism, Molecular Sequence Data, Protein Binding drug effects, Proteins chemistry, Riboflavin pharmacology, Succinate Dehydrogenase chemistry, Succinates metabolism, Iron-Sulfur Proteins metabolism, Leukoencephalopathies genetics, Mutation genetics, Proteins genetics, Succinate Dehydrogenase metabolism
- Abstract
SDHAF1 mutations cause a rare mitochondrial complex II (CII) deficiency, which manifests as infantile leukoencephalopathy with elevated levels of serum and white matter succinate and lactate. Here, we demonstrate that SDHAF1 contributes to iron-sulfur (Fe-S) cluster incorporation into the Fe-S subunit of CII, SDHB. SDHAF1 transiently binds to aromatic peptides of SDHB through an arginine-rich region in its C terminus and specifically engages a Fe-S donor complex, consisting of the scaffold, holo-ISCU, and the co-chaperone-chaperone pair, HSC20-HSPA9, through an LYR motif near its N-terminal domain. Pathogenic mutations of SDHAF1 abrogate binding to SDHB, which impairs biogenesis of holo-SDHB and results in LONP1-mediated degradation of SDHB. Riboflavin treatment was found to ameliorate the neurologic condition of patients. We demonstrate that riboflavin enhances flavinylation of SDHA and reduces levels of succinate and Hypoxia-Inducible Factor (HIF)-1α and -2α, explaining the favorable response of patients to riboflavin., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF